126 related articles for article (PubMed ID: 19590199)
1. Asymmetric dimethylarginine impairs glucose utilization via ROS/TLR4 pathway in adipocytes: an effect prevented by vitamin E.
Yang ZC; Wang KS; Wu Y; Zou XQ; Xiang YY; Chen XP; Li YJ
Cell Physiol Biochem; 2009; 24(1-2):115-24. PubMed ID: 19590199
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide stimulates glucose transport through insulin-independent GLUT4 translocation in 3T3-L1 adipocytes.
Tanaka T; Nakatani K; Morioka K; Urakawa H; Maruyama N; Kitagawa N; Katsuki A; Araki-Sasaki R; Hori Y; Gabazza EC; Yano Y; Wada H; Nobori T; Sumida Y; Adachi Y
Eur J Endocrinol; 2003 Jul; 149(1):61-7. PubMed ID: 12824867
[TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Re reduces insulin resistance through activation of PPAR-γ pathway and inhibition of TNF-α production.
Gao Y; Yang MF; Su YP; Jiang HM; You XJ; Yang YJ; Zhang HL
J Ethnopharmacol; 2013 May; 147(2):509-16. PubMed ID: 23545455
[TBL] [Abstract][Full Text] [Related]
4. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T
Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
[TBL] [Abstract][Full Text] [Related]
5. The association of adipose-derived dimethylarginine dimethylaminohydrolase-2 with insulin sensitivity in experimental type 2 diabetes mellitus.
Zheng J; Wang K; Jin P; Dong C; Yuan Q; Li Y; Yang Z
Acta Biochim Biophys Sin (Shanghai); 2013 Aug; 45(8):641-8. PubMed ID: 23702602
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells.
Jia SJ; Jiang DJ; Hu CP; Zhang XH; Deng HW; Li YJ
Vascul Pharmacol; 2006 Mar; 44(3):143-8. PubMed ID: 16309971
[TBL] [Abstract][Full Text] [Related]
7. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
Feng M; Liu L; Guo Z; Xiong Y
Eur J Pharmacol; 2008 Apr; 584(1):49-56. PubMed ID: 18342305
[TBL] [Abstract][Full Text] [Related]
8. Impact of ADMA (asymmetric dimethylarginine) on physiology with respect to diabetes mellitus and respiratory system BEAS-2B cells (human bronchial epithelial cells).
Galal O; Podlogar J; Verspohl EJ
J Pharm Pharmacol; 2013 Feb; 65(2):253-63. PubMed ID: 23278693
[TBL] [Abstract][Full Text] [Related]
9. α-Lipoic acid ameliorates impaired glucose uptake in LYRM1 overexpressing 3T3-L1 adipocytes through the IRS-1/Akt signaling pathway.
Qin ZY; Zhang M; Guo XR; Wang YM; Zhu GZ; Ni YH; Zhao YP; Qiu J; Kou CZ; Qin R; Cao XG
J Bioenerg Biomembr; 2012 Oct; 44(5):579-86. PubMed ID: 22820890
[TBL] [Abstract][Full Text] [Related]
10. Asymmetric Dimethylarginine Limits the Efficacy of Simvastatin Activating Endothelial Nitric Oxide Synthase.
Hsu CP; Zhao JF; Lin SJ; Shyue SK; Guo BC; Lu TM; Lee TS
J Am Heart Assoc; 2016 Apr; 5(4):e003327. PubMed ID: 27091343
[TBL] [Abstract][Full Text] [Related]
11. Role of endogenous nitric oxide synthase inhibitor in gastric mucosal injury.
Wang L; Zhou Y; Peng J; Zhang Z; Jiang DJ; Li YJ
Can J Physiol Pharmacol; 2008 Mar; 86(3):97-104. PubMed ID: 18418436
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of TFAM protects 3T3-L1 adipocytes from NYGGF4 (PID1) overexpression-induced insulin resistance and mitochondrial dysfunction.
Shi CM; Xu GF; Yang L; Fu ZY; Chen L; Fu HL; Shen YH; Zhu L; Ji CB; Guo XR
Cell Biochem Biophys; 2013 Jul; 66(3):489-97. PubMed ID: 23274913
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of resveratrol derivative BTM-0512 on high glucose-induced cell senescence involves dimethylaminohydrolase/asymmetric dimethylarginine pathway.
Yuan Q; Peng J; Liu SY; Wang CJ; Xiang DX; Xiong XM; Hu CP; Li YJ
Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):630-5. PubMed ID: 20132235
[TBL] [Abstract][Full Text] [Related]
14. Effects of asymmetric dimethylarginine on renal arteries in portal hypertension and cirrhosis.
Segarra G; Cortina B; Mauricio MD; Novella S; Lluch P; Navarrete-Navarro J; Noguera I; Medina P
World J Gastroenterol; 2016 Dec; 22(48):10545-10556. PubMed ID: 28082806
[TBL] [Abstract][Full Text] [Related]
15. Anthocyanins from Purple Corn Ameliorated Tumor Necrosis Factor-α-Induced Inflammation and Insulin Resistance in 3T3-L1 Adipocytes via Activation of Insulin Signaling and Enhanced GLUT4 Translocation.
Luna-Vital D; Weiss M; Gonzalez de Mejia E
Mol Nutr Food Res; 2017 Dec; 61(12):. PubMed ID: 28759152
[TBL] [Abstract][Full Text] [Related]
16. Quercetin differently regulates insulin-mediated glucose transporter 4 translocation under basal and inflammatory conditions in adipocytes.
Xu M; Hu J; Zhao W; Gao X; Jiang C; Liu K; Liu B; Huang F
Mol Nutr Food Res; 2014 May; 58(5):931-41. PubMed ID: 24343960
[TBL] [Abstract][Full Text] [Related]
17. IGF-I stimulates reactive oxygen species (ROS) production and inhibits insulin-dependent glucose uptake via ROS in 3T3-L1 adipocytes.
Fukuoka H; Iida K; Nishizawa H; Imanaka M; Takeno R; Iguchi G; Takahashi M; Okimura Y; Kaji H; Chihara K; Takahashi Y
Growth Horm IGF Res; 2010 Jun; 20(3):212-9. PubMed ID: 20185348
[TBL] [Abstract][Full Text] [Related]
18. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y impairs insulin-stimulated translocation of glucose transporter 4 in 3T3-L1 adipocytes through the Y1 receptor.
Gericke MT; Schröder T; Kosacka J; Nowicki M; Klöting N; Spanel-Borowski K
Mol Cell Endocrinol; 2012 Jan; 348(1):27-32. PubMed ID: 21801810
[TBL] [Abstract][Full Text] [Related]
20. Cyanidin-3-rutinoside increases glucose uptake by activating the PI3K/Akt pathway in 3T3-L1 adipocytes.
Choi KH; Lee HA; Park MH; Han JS
Environ Toxicol Pharmacol; 2017 Sep; 54():1-6. PubMed ID: 28667861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
